Endocrine Therapy of Breast Cancer IV
Endocrine Therapy of Breast Cancer IV
复制标题
乳腺癌内分泌治疗IV
DOI：
--
复制
发表时间：
1990
期刊：
影响因子：
--
通讯作者：
A. Goldhirsch
中科院分区：
文献类型：
--
作者：
A. Goldhirsch
雌激素和黄体酮在人乳腺癌发生中的作用。-类固醇激素受体的分子遗传学。乳腺癌的预后因素。淋巴结阴性乳腺癌患者的预后因素长期他莫昔芬治疗：一种适合乳腺癌的化疗抑制疗法。他莫昔芬作为转移性乳腺癌的激动剂。- LHRH激动剂Zoladex治疗绝经前和围绝经期晚期乳腺癌的国际经验综述-淋巴结阴性乳腺癌的辅助全身治疗。绝经前乳腺癌患者的辅助化疗是有效的，而不是通过抑制卵巢功能。-描述治疗益处的替代方法，包括生活质量考虑因素。
Role of Oestrogen and Progestin in Human Mammary Carcinogenesis.- Molecular Genetics of Steroid Hormone Receptors.- Prognostic Factors in Breast Cancer.- Prognostic Factors in Node-Negative Breast Cancer Patients.- Long-Term Tamoxifen Therapy: An Appropriate Chemosuppressive Treatment for Breast Cancer.- Tamoxifen as an Agonist for Metastatic Breast Cancer.- A Review of the International Experience with the LHRH Agonist Zoladex in the Treatment of Advanced Breast Cancer in Pre- and Perimenopausal Women.- Adjuvant Systemic Therapy in Node-Negative Breast Cancer.- Adjuvant Chemotherapy in Premenopausal Breast Cancer Patients is Effective by Means Other than Ovarian Function Suppression.- Alternative Methods for Describing Treatment Benefit Including Quality-of-Life Considerations.